Clinical Trial: Clinical Observational Study on the Dynamics of Cytomegalovirus-Specific T Cells in Patients Receiving Letermovir for Cytomegalovirus Infection Prevention Following Allogeneic Hematopoietic Stem Cell Transplantation (China)

Posted On: 2026-08-18

China, Aug. 18 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical Observational Study on the Dynamics of Cytomegalovirus-Specific T Cells in Patients Receiving Letermovir for Cytomegalovirus Infection Prevention Following Allogeneic Hematopoietic Stem Cell Transplantation'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130223

Registration Time: 2026/08/17

Type: Observational study

Primary Sponsor: Guabgzhou First People‘s Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=332399

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Clinical Observational Study on the Dynamics of Cytomegalovirus-Specific T Cells in Patients Receiving Letermovir for Cytomegalovirus Infection Prevention Following Allogeneic Hematopoietic Stem Cell Transplantation (China)